Skin cancer risk for patients with vitiligo does not increase after UVB phototherapy


For patients with vitiligo, extended treatment with narrowband ultraviolet B (UVB) phototherapy does not lead to an increase in their risk of developing skin cancer, according to a new study. The study, published online ahead of print in JAMA Dermatology (Mar. 11, 2020), took a deeper look at UVB phototherapy, which is often used for vitiligo patients.

#melanoma #vitiligo #nonmelanomaskincancer #nmsc #UVBlightphototherapy #narrowbandUVB

14 views

More Publications by © Chronicle Companies

SkinDaily, Pediatric Chronicle, The Chronicle of Neurology + Psychiatry, Canadian Journal of Medical Cannabis

  • Twitter - Black Circle
  • Facebook - Black Circle
  • YouTube - Black Circle

© Chronicle Companies 2020